Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non–small cell lung carcinomas using fine-needle aspiration cases-Reference-Cited by-同舟云学术

Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non–small cell lung carcinomas using fine-needle aspiration cases

Published:2016-08 Issue: Volume:54 Page:8-16
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Sharma Rajni,Wang Yuting,Chen Li,Gurda Grzegorz T.,Geddes Susan,Gabrielson Edward,Askin Frederic,Li Qing Kay

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference37 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart;Travis,2015

3. The 2015 World Health Organization classification of lung tumors. impact of genetic, clinical and radiologic advances since 2004 classification;Travis;J Thorac Oncol,2015

4. Comprehensive genomic characterization of squamous cell lung cancers;Cancer Genome Atlas Research Network;Nature,2012

5. Comprehensive molecular profiling of lung adenocarcinoma. Cancer Genome Atlas Research Network;Cancer Genome Atlas Research Network;Nature,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role and Associated Factors of Liquid-Based Cytology of Bronchoalveolar Lavage Fluid in Lung Cancer Diagnosis: A Prospective Study;Cureus;2023-11-08

2. An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin;Advances in Anatomic Pathology;2020-03-19

3. Subtyping and EGFR mutation testing from blocks of cytological materials, based on liquid‐based cytology for lung cancer at bronchoscopic examinations;Diagnostic Cytopathology;2020-03-03

4. Use of dual-marker staining to differentiate between lung squamous cell carcinoma and adenocarcinoma;Journal of International Medical Research;2019-12-27

5. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy;Seminars in Cancer Biology;2018-10